Longwood Healthcare Leaders’ Flagship Meeting Boston CEO to Convene Life Science Thought Leaders Across Government, Pharma, Biotech, Academia, and Research September 24, 2024
Engrail Therapeutics Initiates ENX-104 Clinical Program for the Treatment of Major Depressive Disorder Characterized by Anhedonia September 18, 2024
AAVantgarde Announces First Patient Dosed with AAVB-081 in FIH Phase 1/2 LUCE-1 Study for Retinitis Pigmentosa Related to USH1B September 16, 2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update August 12, 2024
Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update August 12, 2024
